חזרה לתוצאות החיפוש

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Arizona Oncology Associates, Tucson, Arizona, United States

  • University of Southern California, Los Angeles, California, United States

  • Hoag Memorial Hospital, Newport Beach, California, United States

  • Rocky Mountain Cancer Centers, Denver, Colorado, United States

    Study coordinator · 303-388-4876

  • Yale Cancer Center, New Haven, Connecticut, United States

  • Christiana Care Helen F. Graham Cancer Center, Newark, Delaware, United States

  • John Hopkins Kimmer Cancer Center, Washington D.C., District of Columbia, United States

  • Florida Cancer Specialists, Daytona Beach, Florida, United States

    Study coordinator · 386-231-4060

  • Florida Cancer Specialists, Fleming Island, Florida, United States

  • Ocala Oncology Center, Ocala, Florida, United States

    Study coordinator · 352-547-1958

  • AdventHealth Research Institute, Orlando, Florida, United States

  • Illinois Cancer Specialists, Arlington Heights, Illinois, United States

  • University of Illinois, Chicago, Illinois, United States

  • Indiana University, Indianapolis, Indiana, United States

  • Norton Cancer Institute, Louisville, Kentucky, United States

  • American Oncology Partners, P.A. - The Center for Cancer & Blood Disorders, Bethesda, Maryland, United States

    Study coordinator · 301-571-2016

  • Maryland Oncology Hematology, Silver Spring, Maryland, United States

    Study coordinator · 301-933-3216

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

  • START Midwest, Grand Rapids, Michigan, United States

    Study coordinator · 616-954-5554

  • Regions Hospital Cancer Care Center, Saint Paul, Minnesota, United States

    Study coordinator · 651-254-3602

  • Washington University in St Louis, St Louis, Missouri, United States

  • Nebraska Cancer Center Oncology Hematology West P.C., Omaha, Nebraska, United States

    Study coordinator · 402-691-6971

  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Study coordinator · 732-235-3253

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • Stony Brook University, Stony Brook, New York, United States

  • University of Cincinnati, Cincinnati, Ohio, United States

    Study coordinator · 513-584-5680

  • Zangmeister Cancer Center, Columbus, Ohio, United States

  • The University of Toledo, Toledo, Ohio, United States

  • University of Oklahoma, Oklahoma City, Oklahoma, United States

    Study coordinator · 405-271-8001

  • University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

  • Medical University of South Carolina, Charleston, South Carolina, United States

  • Sarah Cannon Research Institute, Nashville, Tennessee, United States

    Study coordinator · 615-524-4203

  • Vanderbilt - Ingram Cancer Center, Nashville, Tennessee, United States

  • Texas Oncology - Dallas, Dallas, Texas, United States

    Study coordinator · 214-370-1000

  • START Dallas, Fort Worth, Texas, United States

    Study coordinator · 682-350-3010

  • The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Texas Oncology - Paris, Paris, Texas, United States

    Study coordinator · 903-785-0031

  • NEXT Oncology, San Antonio, Texas, United States

  • NEXT Oncology Virginia, Fairfax, Virginia, United States

    Study coordinator · 703-280-5290

  • Northwest Medical Specialties, Tacoma, Washington, United States

  • Northwest Cancer Specialists, Vancouver, Washington, United States

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)